Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Plos One|April 14, 2017
C1q ablation exacerbates amyloid deposition: A study in a transgenic mouse model of ATTRV30M amyloid neuropathyElena Panayiotou, Eleni Fella, Revekka Papacharalambous, et al.
Neuromuscular Disorders : NMD|October 13, 2019
A novel case of inclusion body myositis and myasthenia gravisSakis Lambrianides, Evgenios Kinnis, Michele Cleanthous, et al.
Frontiers in Molecular Neuroscience|May 26, 2017
Pharmacological Stimulation of Phagocytosis Enhances Amyloid Plaque Clearance; Evidence from a Transgenic Mouse Model of ATTR NeuropathyEleni Fella, Kleitos Sokratous, Revekka Papacharalambous, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|March 7, 2025
A dose escalation and safety study of AAVrh10-mediated Schwann cell-targeted gene therapy for CMT1XMelina Christou, Irene Sargiannidou, Revekka Papacharalambous, et al.
International Journal of Molecular Sciences|June 26, 2026
Semaglutide Selectively Improves Metabolic and Cognitive Function in 5xFAD MiceLucy Shahabian, Demos Kynigopoulos, Revekka Papacharalambous, et al.
Biochimie|June 12, 2022
Stbd1-deficient mice display insulin resistance associated with enhanced hepatic ER-mitochondria contactStyliana Kyriakoudi, Andria Theodoulou, Louiza Potamiti, et al.
Molecular Therapy. Nucleic Acids|April 8, 2026
Safety, efficacy, and distal nerve Schwann cell biodistribution in mice and NHPs to support translation of AAV9 RNAi therapy for CMT1AMarina Stavrou, Lindsay M Wallace, Merlin P Thangaraj, et al.
Pageof 1